Rhenman & Partners Asset Management’s 1Life Healthcare ONEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-375,250
Closed -$2.94M 93
2022
Q2
$2.94M Hold
375,250
0.33% 66
2022
Q1
$4.16M Sell
375,250
-154,750
-29% -$1.73M 0.41% 68
2021
Q4
$9.2M Buy
530,000
+110,000
+26% +$2.13M 0.61% 57
2021
Q3
$8.51M Buy
420,000
+90,000
+27% +$2.31M 0.6% 53
2021
Q2
$10.9M Buy
330,000
+130,000
+65% +$4.91M 0.74% 55
2021
Q1
$7.82M Buy
+200,000
New +$9.39M 0.55% 56

Other funds holding ONEM

Rhenman & Partners Asset Management's ONEM Position: Q3 2022 in Review

Rhenman & Partners Asset Management sold out of 1Life Healthcare (ONEM) in Q3 2022, closing a stake of 375,250 shares — an estimated $2.94M sold.

Rhenman & Partners Asset Management first reported a position in ONEM in Q1 2021 and held it in 6 quarters. The position peaked at $10.9M in Q2 2021. 222 funds tracked by Wall St. Rank hold ONEM as of Q3 2022.

  • Rhenman & Partners Asset Management reported no remaining 1Life Healthcare position as of Q3 2022 after selling out during the quarter.
  • Rhenman & Partners Asset Management sold 375,250 1Life Healthcare shares in Q3 2022, an estimated $2.94M.
  • Rhenman & Partners Asset Management first reported a position in 1Life Healthcare in Q1 2021 and held it in 6 quarters.
  • Rhenman & Partners Asset Management's 1Life Healthcare position peaked at $10.9M in Q2 2021.
  • 222 funds tracked by Wall St. Rank held 1Life Healthcare as of Q3 2022.

Based on Rhenman & Partners Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.